Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsule Endoscopy | 5 | 2019 | 38 | 0.980 |
Why?
|
| Cathartics | 1 | 2017 | 11 | 0.550 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2019 | 86 | 0.540 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 34 | 0.530 |
Why?
|
| Colitis, Microscopic | 1 | 2015 | 1 | 0.500 |
Why?
|
| Ileostomy | 1 | 2015 | 25 | 0.490 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 166 | 0.440 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 370 | 0.420 |
Why?
|
| Diet | 1 | 2017 | 645 | 0.390 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2021 | 117 | 0.330 |
Why?
|
| Endoscopy, Digestive System | 2 | 2018 | 31 | 0.190 |
Why?
|
| Colonoscopy | 2 | 2018 | 104 | 0.180 |
Why?
|
| Suture Techniques | 1 | 2021 | 88 | 0.180 |
Why?
|
| Hematemesis | 1 | 2018 | 5 | 0.160 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 43 | 0.150 |
Why?
|
| Viral Core Proteins | 2 | 2007 | 30 | 0.120 |
Why?
|
| Remission Induction | 1 | 2015 | 141 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 125 | 0.120 |
Why?
|
| Patient Selection | 1 | 2017 | 463 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 609 | 0.110 |
Why?
|
| Dendritic Cells | 3 | 2012 | 508 | 0.110 |
Why?
|
| Interleukins | 1 | 2012 | 78 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 463 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 2 | 2012 | 88 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2021 | 5347 | 0.080 |
Why?
|
| Risk Factors | 2 | 2018 | 5158 | 0.080 |
Why?
|
| Humans | 11 | 2021 | 60913 | 0.080 |
Why?
|
| Standard of Care | 2 | 2019 | 27 | 0.080 |
Why?
|
| Middle Aged | 8 | 2021 | 16857 | 0.080 |
Why?
|
| Macrophage Activation | 1 | 2007 | 119 | 0.070 |
Why?
|
| Endotoxins | 1 | 2007 | 78 | 0.070 |
Why?
|
| Hepacivirus | 2 | 2007 | 140 | 0.060 |
Why?
|
| Aged | 5 | 2021 | 13873 | 0.060 |
Why?
|
| Male | 9 | 2021 | 28424 | 0.060 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 434 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2007 | 551 | 0.060 |
Why?
|
| Time Factors | 3 | 2018 | 3661 | 0.060 |
Why?
|
| Female | 9 | 2021 | 31706 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 27 | 0.050 |
Why?
|
| Isoantigens | 1 | 2003 | 72 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5289 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 784 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2003 | 165 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2003 | 149 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2003 | 93 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 309 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6192 | 0.050 |
Why?
|
| Monocytes | 3 | 2012 | 346 | 0.050 |
Why?
|
| Sutures | 1 | 2021 | 33 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2003 | 143 | 0.050 |
Why?
|
| Ethanol | 1 | 2003 | 309 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 4 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 101 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 915 | 0.040 |
Why?
|
| Melena | 1 | 2018 | 5 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 42 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 95 | 0.040 |
Why?
|
| Stents | 1 | 2021 | 459 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2012 | 1303 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 398 | 0.030 |
Why?
|
| Anemia | 1 | 2018 | 120 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 168 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 690 | 0.030 |
Why?
|
| Adult | 5 | 2018 | 16211 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 933 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1271 | 0.030 |
Why?
|
| Vascular Malformations | 1 | 2013 | 20 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2012 | 33 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 2012 | 18 | 0.030 |
Why?
|
| Myeloid Cells | 2 | 2003 | 92 | 0.030 |
Why?
|
| Interferons | 1 | 2012 | 63 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 3188 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 201 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2013 | 311 | 0.020 |
Why?
|
| Inflammation | 2 | 2007 | 1113 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 800 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2007 | 42 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 219 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2012 | 766 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 423 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 348 | 0.020 |
Why?
|
| Hospitalization | 1 | 2013 | 1321 | 0.020 |
Why?
|
| United States | 1 | 2018 | 7657 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 463 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 587 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1088 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 635 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 218 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2003 | 111 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 444 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1016 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 306 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 972 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1044 | 0.010 |
Why?
|